Business Context and Reporting Period
This Form 8-K is a current report filed by Oncocyte Corporation (not Insight Molecular Diagnostics Inc.) on March 10, 2022. The filing serves to announce the company's financial results for the three and twelve months ended December 31, 2021. The registrant is incorporated in California and trades on The Nasdaq Stock Market LLC under the symbol OCX.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the body of this 8-K document.
Material Changes
The document does not detail specific material changes versus prior periods. It solely references the issuance of a press release containing the comparative financial results for the periods ended December 31, 2021.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing includes a standard disclaimer regarding forward-looking statements (using terms like "may," "will," "believes," etc.). It warns that actual results may differ materially due to factors outlined in the "Risk Factors" section of the company's Annual Report on Form 10-K.
- Management Commentary: No specific management commentary or guidance is provided in the 8-K text itself; investors are directed to the attached press release for details.
- Legal Status: Information in Item 2.02 and Exhibit 99.1 is deemed "furnished" and not "filed" under the Exchange Act, meaning it is not subject to the same liability standards as filed documents.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (the press release dated March 10, 2022), as they are absent from the 8-K summary text.
- Confirm the company name is Oncocyte Corporation, noting the discrepancy with the "Insight Molecular Diagnostics Inc." label in the request metadata.
- Review the "Risk Factors" in the most recent Form 10-K to understand the variables affecting the forward-looking statements mentioned in this filing.
- Check the company's cash runway and burn rate in the full press release, as this 8-K does not disclose liquidity details.